PHLDA1
From Wikipedia, the free encyclopedia
Pleckstrin homology-like domain, family A, member 1
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | PHLDA1; DT1P1B11; MGC131738; PHRIP; TDAG51 | |||||||||||||
External IDs | OMIM: 605335 MGI: 1096880 HomoloGene: 7203 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 22822 | 21664 | ||||||||||||
Ensembl | ENSG00000139289 | ENSMUSG00000020205 | ||||||||||||
Uniprot | Q8WV24 | Q62392 | ||||||||||||
Refseq | NM_007350 (mRNA) NP_031376 (protein) |
NM_009344 (mRNA) NP_033370 (protein) |
||||||||||||
Location | Chr 12: 74.71 - 74.71 Mb | Chr 10: 110.91 - 110.91 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Pleckstrin homology-like domain, family A, member 1, also known as PHLDA1, is a human gene.[1]
This gene encodes an evolutionarily conserved proline-histidine rich nuclear protein. The encoded protein may play an important role in the anti-apoptotic effects of insulin-like growth factor-1.[1]
[edit] References
[edit] Further reading
- Reddy PH, Stockburger E, Gillevet P, Tagle DA (1998). "Mapping and characterization of novel (CAG)n repeat cDNAs from adult human brain derived by the oligo capture method.". Genomics 46 (2): 174–82. doi: . PMID 9417904.
- Kuske MD, Johnson JP (2000). "Assignment of the human PHLDA1 gene to chromosome 12q15 by radiation hybrid mapping.". Cytogenet. Cell Genet. 89 (1-2): 1. PMID 10894922.
- Hinz T, Flindt S, Marx A, et al. (2001). "Inhibition of protein synthesis by the T cell receptor-inducible human TDAG51 gene product.". Cell. Signal. 13 (5): 345–52. PMID 11369516.
- Neef R, Kuske MA, Pröls E, Johnson JP (2002). "Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.". Cancer Res. 62 (20): 5920–9. PMID 12384558.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Hossain GS, van Thienen JV, Werstuck GH, et al. (2003). "TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia.". J. Biol. Chem. 278 (32): 30317–27. doi: . PMID 12738777.
- Oberg HH, Sipos B, Kalthoff H, et al. (2005). "Regulation of T-cell death-associated gene 51 (TDAG51) expression in human T-cells.". Cell Death Differ. 11 (6): 674–84. doi: . PMID 15002043.
- Toyoshima Y, Karas M, Yakar S, et al. (2004). "TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival.". J. Biol. Chem. 279 (24): 25898–904. doi: . PMID 15037619.
- Meier-Noorden M, Flindt S, Kalinke U, Hinz T (2004). "A CpG-rich bidirectional promoter induces the T-cell death-associated gene 51 and downregulates an inversely oriented transcript during early T-cell activation.". Gene 338 (2): 197–207. doi: . PMID 15315823.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173–8. doi: . PMID 16189514.